StockData
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC (BCYC) stock

BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.18−0.19 (-5.64%)

Close on Nov 16, 2026Market cap $222.90MP/E –Yield 0.00%

Bicycle Therapeutics cash

Cash and short-term investments held at the end of each period.

Bicycle Therapeutics's cash was $469.93M at Sep 30, 2026. For fiscal 2025 it was $628.11M, down 28.6% from the year before. The highest annual figure on record is $880.07M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$628.11M-28.6%
FY2024Dec 31, 2024$880.07M+67.2%
FY2023Dec 31, 2023$526.42M+55.2%
FY2022Dec 31, 2022$339.15M-22.7%
FY2021Dec 31, 2021$438.68M+222.6%
FY2020Dec 31, 2020$135.99M+47.6%
FY2019Dec 31, 2019$92.12M+45.3%
FY2018Dec 31, 2018$63.38M-6.3%
FY2017Dec 31, 2017$67.66M+619.7%
FY2016Dec 31, 2016$9.40M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$469.93M-27.5%
Q2 FY2026Jun 30, 2026$510.05M-29.3%
Q1 FY2026Mar 31, 2026$559.47M-29.4%
Q4 FY2025Dec 31, 2025$628.11M-28.6%
Q3 FY2025Sep 30, 2025$648.33M-27.2%
Q2 FY2025Jun 30, 2025$721.45M-25.0%
Q1 FY2025Mar 31, 2025$792.97M+73.5%
Q4 FY2024Dec 31, 2024$880.07M+67.2%
Q3 FY2024Sep 30, 2024$890.86M+55.7%
Q2 FY2024Jun 30, 2024$961.36M+182.4%
Q1 FY2024Mar 31, 2024$457.00M+55.5%
Q4 FY2023Dec 31, 2023$526.42M+55.2%
Q3 FY2023Sep 30, 2023$572.09M+58.3%
Q2 FY2023Jun 30, 2023$340.43M-8.7%
Q1 FY2023Mar 31, 2023$293.82M-27.9%
Q4 FY2022Dec 31, 2022$339.15M-22.7%
Q3 FY2022Sep 30, 2022$361.47M+39.3%
Q2 FY2022Jun 30, 2022$372.77M+87.6%
Q1 FY2022Mar 31, 2022$407.37M+107.9%
Q4 FY2021Dec 31, 2021$438.68M+222.6%
Q3 FY2021Sep 30, 2021$259.52M+73.2%
Q2 FY2021Jun 30, 2021$198.74M+105.1%
Q1 FY2021Mar 31, 2021$195.90M+78.7%
Q4 FY2020Dec 31, 2020$135.99M+47.6%
Q3 FY2020Sep 30, 2020$149.84M+56.2%
Q2 FY2020Jun 30, 2020$96.91M-10.7%
Q1 FY2020Mar 31, 2020$109.64M+84.7%
Q4 FY2019Dec 31, 2019$92.12M+45.3%
Q3 FY2019Sep 30, 2019$95.95M+100.2%
Q2 FY2019Jun 30, 2019$108.54M+103.2%
Q1 FY2019Mar 31, 2019$59.36M-12.3%
Q4 FY2018Dec 31, 2018$63.38M+574.1%
Q3 FY2018Sep 30, 2018$47.92M–
Q2 FY2018Jun 30, 2018$53.40M–
Q4 FY2017Dec 31, 2017$67.66M–
Q4 FY2016Dec 31, 2016$9.40M–

More Bicycle Therapeutics figures

See a number that looks wrong?